Beta Bionics (BBNX) Long-Term Investments (2025 - 2026)
Beta Bionics' (BBNX) quarterly Long-Term Investments came in at $44.6 million in Q2 2026, up 43.34% year-over-year from $31.1 million in Q2 2025, and up 12.0% quarter-over-quarter from $39.9 million in Q1 2026.
Powered by 
Analysis
Beta Bionics (BBNX) Long-Term Investments (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Long-Term Investments across 2 years of filings, most recently posting $44.6 million for Q2 2026.
- In Q2 2026, Long-Term Investments rose 43.34% year-over-year to $44.6 million; the TTM figure through Jun 2026 stood at $44.6 million (up 43.34% YoY), while the FY2025 annual figure was $45.4 million, changed N/A from the prior year.
- Long-Term Investments came in at $44.6 million for Q2 2026 at Beta Bionics, up from $39.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $64.0 million in Q1 2025 to a low of $31.1 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn | 44.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.65 Mn |
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | 45.43 Mn |
| Sep 30, 2025 | 45.33 Mn |
| Jun 30, 2025 | 31.15 Mn |
| Mar 31, 2025 | 64.00 Mn |